An analysis of firm-level innovation strategies in the US biotechnology industry

Technovation

Volumn 27, Issue 1-2, 2007, Pages 4-14

  Hall, Linda A ^a   Bagchi Sen, Sharmistha ^b  

^a STATE UNIVERSITY OF NEW YORK AT FREDONIA   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Biotechnology; Innovation; R D intensity

Indexed keywords

COMPETITION; INDUSTRIAL MANAGEMENT; MARKETING; RESEARCH AND DEVELOPMENT MANAGEMENT; STRATEGIC PLANNING;

BIOTECHNOLOGY FIRMS; INNOVATION STRATEGIES; MARKET ACCESS;

BIOTECHNOLOGY;

EID: 33845330258     PISSN: 01664972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.technovation.2006.07.001     Document Type: Article

References (36)

1. Amir-Aslani A., and Negassi S. Is technology integration the solution to biotechnology's low research and development productivity?. Technovation 26 (2006) 573-582
2. Arora A., and Gambardella A. Evaluating technological information and utilizing it. Journal of Economic Behavior and Organization 24 (1994) 91-114
3. Audretsch D. The role of small firms in US biotechnology clusters. Small Business Economics 17 3 (2001) 3-15
4. Bagchi-Sen S. Firm-specific characteristics of R&D collaborators and non-collaborators in US biotechnology clusters and elsewhere. International Journal of Technology and Globalization 1 (2004)
5. Baptista R., and Swann P. Do firms in clusters innovate more?. Research Policy 27 5 (1998) 525-540
6. Boer H., Caffyn S., Corso M., Coughlan P., Gieskes J., Magnusson M., Pavesi S., and Ronchi S. Knowledge and continuous innovation. The CIMA methodology. International Journal of Operations & Production Management 21 4 (2001) 490-503
7. Chakrabarti A.K., and Weisenfeld U. An empirical analysis of innovation strategies of biotechnology firms in the US. Journal of Engineering and Technology Management 8 3/4 (1991) 243-260
8. Coombs J., and Deeds D. International alliances as sources of capital: Evidence from the biotechnology industry. The Journal of High Technology Management Research 11 2 (2000) 235-253
9. Cortwright J., and Mayer H. Signs of Life: The Growth of Biotechnology Centers in the US (2002), The Brookings Institution Center on Urban and Metropolitan Policy, Washington, DC
10. Deeds D.L., and Hill C.W.L. Strategic alliances and the rate of new product development: an empirical study of entrepreneurial biotechnology firms. Journal of Business Venturing 11 (1996) 41-55
11. della Valle F., and Gambardella A. 'Biological' revolution and strategies for innovation in pharmaceutical companies. R&D Management 23 4 (1993) 287-302
12. Ernst &Young. Convergence The Biotechnology Industry Report (2000), Ernst & Young, LLP
13. Feldman M.P., and Florida R. The geographic sources of innovation: Technological infrastructure and product innovation in the United States. Annals of the Association of American Geographers 84 2 (1994) 210-229
14. Freeman C. Networks of innovators: a synthesis of research issues. Research Policy 20 (1991) 499-514
15. Greis N.P., Dibner M.D., and Bean A.S. External partnering as a response to innovation barriers and global competition in biotechnology. Research Policy 24 (1995) 609-630
16. Hagedoorn J. Strategic technology partnering during the 1980s: trends, networks, and corporate patterns in non-core technologies. Research Policy 24 (1995) 207-231
17. Hagedoorn J. Inter-firm R&D partnerships: an overview of major trends and patterns since 1960. Research Policy 31 (2002) 477-492
18. Hall, L., 1999. Innovation and collaboration in the US biotechnology industry. Unpublished doctoral dissertation, State University of New York at Buffalo.
19. Hall L., and Bagchi-Sen S. An analysis of R&D, innovation and business performance in the US biotechnology industry. International Journal of Biotechnology 3 3/4 (2001) 267-286
20. Hall L., and Bagchi-Sen S. A study of R&D, innovation, and business performance in the Canadian biotechnology industry. Technovation 22 (2002) 231-244
21. Hamilton W.F., Vila J., and Dibner M.D. Patterns of strategic choice in emerging firms: Positioning for innovation in biotechnology. California Management Review 32 3 (1990) 73-86
22. Institute for Biotechnology Information. Biotechnology Industry Guide (1996), Institute for Biotechnology Information, Research Triangle Park, NC
23. Lahteenmaki R., and DeFrancesco L. Public biotechnology 2002-the numbers. Nature Biotechnology 21 6 (2003) 607-612
24. Lee Jr. K.B., and Burrill G.S. Biotech 97: Alignment (1996), Ernst & Young, LLP, Palo Alto, CA
25. Lev B., and Zarowin P. The boundaries of financial reporting and how to extend them. Journal of Accounting Research 37 2 (1999) 353-385
26. MacKenzie R. Why biotech needs business. Buffalo Business 13 (2005) 10-15
27. Mowery D.C., and Rosenberg N. Technology and the Pursuit of Economic Growth (1989), Cambridge University Press, Cambridge, MA
28. Nambisan S. Complementary product integration by high-technology new ventures: the role of initial technology strategy. Management Science 48 3 (2002) 382-398
29. North American Biotechnology Directory (2000), Atlantic Communications, Houston, TX (formerly I.E.I. Publishing)
30. Oinas P., and Malecki E.J. The evolution of technologies in time and space: from national and regional to spatial innovation systems. International Regional Science Review 25 (2002) 102-131
31. Persidis A. Strategies of biotechnology firms towards new platform technologies. International Journal of Biotechnology 30 1/2 (2001) 23-32
32. Pisano G.P., Shan W., and Teece D.J. Joint ventures and collaboration in the biotechnology industry. In: Mowery D. (Ed). International Collaborative Ventures in US Manufacturing (1988), Ballinger Publishing Co., Cambridge, MA
33. Rothaermel F. Complimentary assets, strategic alliances, and the incumbent's advantage: an empirical study of industry and firm effects in the biopharmaceutical industry. Research Policy 30 8 (2001) 1235-1251
34. Sabourin V., and Pinsonneault I. Strategic formation of competitive high technology clusters. International Journal of Technology Management 13 2 (1997) 165-178
35. Shan W., Walker G., and Kogut B. Interfirm cooperation and startup innovation in the biotechnology industry. Strategic Management Journal 15 (1994) 387-394
36. Terziovski M., and Morgan J.P. Management practices and strategies to accelerate the innovation cycle in the biotechnology industry. Technovation 26 (2006) 545-552